Introduction to randomized controlled clinical trials, second edition

Introduction to Randomized Controlled Clinical Trials, Second Edition

Volumn , Issue , 2006, Pages 1-285

  Matthews, John N S ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85057234919     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Book

References (62)

1. Altman, D.G. (1991), Practical Statistics for Medical Research, Chapman & Hall/CRC, London.
2. Altman, D.G. (1998), Confidence intervals for the number needed to treat, British Medical Journal, 317, 1309–1312.
3. Appelman, Y.E.A., Piek, J.J., Strikwerda, S., Tijssen, J.G.P., de Feyter, P.J., David, G.K., Serruys, P.W., Margolis, J.R., Loelemay, M.J., Montauban van Swijndregt, E.W.J., Koolen, J.J. (1996), Randomised trial of excimer laser angioplasty versus balloon angioplasty for treatment of obstructive coronary artery disease, Lancet, 347, 79–84.
4. Armitage, P. (1975), Sequential Medical Trials, 2nd ed., Blackwell, Oxford.
5. Armitage, P., Berry, G., Matthews, J.N.S. (2002), Statistical Methods in Medical Research, 4th ed., Blackwell, Oxford.
6. Armitage, P., Hills, M. (1982), The two-period crossover trial, The Statistician, 31, 119–131.
7. Armitage, P., McPherson, C.K., Rowe, B.C. (1969), Repeated significance tests on accumulating data, Journal of the Royal Statistical Society: Series A, 132, 235–244.
8. Begg, C.B. (1990), On inferences from Wei’s biased coin design for clinical trials, Biometrika, 77, 467–484.
9. Brandjes, D.P.M., Buller, H.R., Heijboer, H., Huisman, M.V., de Rijk, M., Jagt, H., ten Cate, J.W. (1997), Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis, Lancet, 349, 759–762.
10. Chase, P.J. (1970), Combinations of M out of N objects, Communications of the Association for Computing Machinery, 13, 368.
11. Cockburn, F., Belton, N.R., Purvis, R.J., Giles, M.M., Brown, J.K., Turner, T.L., Wilkinson, E.M., Forfar, J.O., Barrie, W.J.M., McKay, G.S., Pocock, S.J. (1980), Maternal vitamin D intake and mineral metabolism in mothers and their newborn infants. British Medical Journal, 281, 11–14.
12. Collaborative Group on Antenatal Steroid Therapy (1981), Effect of antenatal dexamethasone therapy on prevention of respiratory distress syndrome, American Journal of Obstetrics and Gynecology, 141, 276–287.
13. Collett, D. (2002), Modelling Binary Data, 2nd ed., Chapman & Hall/CRC Press, Boca Raton, FL.
14. Collett, D. (2003), Modelling Survival Data in Medical Research, 2nd ed., Chapman & Hall/CRC Press, Boca Raton, FL.
15. Cox, D.R. (1972), Regression models and life-tables (with discussion), Journal of the Royal Statistical Society: Series B, 34, 187–220.
16. Crowley, P., Chalmers, I., Keirse, M.J.N.C. (1990), The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials, British Journal of Obstetrics and Gynaecology, 97, 11–25.
17. Efron, B. (1971), Forcing a sequential experiment to be balanced, Biometrika, 58, 403–417.
18. Ellenberg, S.S., Fleming, T.R., DeMets, D.L. (2002), Data Monitoring Committees in Clinical Trials: A Practical Perspective, Wiley, Chichester.
19. European Coronary Surgery Study Group (1979), Coronary-artery bypass surgery in stable angina pectoris: survival at two years, Lancet, i, 889–893.
20. Eysenck, H.J. (1995), Problems with meta-analysis, in Systematic Reviews, Eds., Chalmers, I. and Altman, D.G., BMJ Publishing, London, pp. 64–74.
21. Fentiman, I.S., Rubens, R.D., Hayward, J.L. (1983), Control of pleural effusions in patients with breast-cancer — a randomized trial, Cancer, 52, 737–739.
22. Fisher, B., Redmond, C., Brown, A., Wickerham, D.L., Wolmark, N., Allegra, J., Escher, G., Lippman, M., Savlov, E., Wittliff, J., Fisher, E.R., Plotkin, D., Bowman, D., Wolter, J., Bornstein, R., Desser, R., Frelick, R. (1983), Influence of tumor estrogen and progesterone receptor levels on the response to tamoxifen and chemotherapy in primary breast cancer, Journal of Clinical Oncology, 1, 227–241.
23. Fleming, T.R., Harrington, D.P., O’Brien, P.C. (1984), Designs for group sequential tests, Controlled Clinical Trials, 5, 348–361.
24. Gail, M., Simon, R. (1985), Testing for qualitative interactions between treatment effects and patient subsets, Biometrics, 41, 361–372.
25. Giardiello, F.M., Hamilton, S.R., Krush, A.J., Piantadosi, S., Hylind, L.M., Celano, P., Booker, S.V., Robinson, C.R., Offerhaus, G.J. (1993), Treatment of colonic and rectal adenomas with Sulindac in familial adenomatous polyposis, New England Journal of Medicine, 328, 1313–1316.
26. Gordon, P.M., Diffey, B.L., Matthews, J.N.S., Farr, P.M. (1999), A randomized comparison of narrow-band TL-01 phototherapy and PUVA photochemotherapy for psoriasis, Journal of the American Academy of Dermatology, 41, 728–732.
27. Grosskurth, H., Mosha, F., Todd, J., Mwijarubi, E., Klokke, A., Senkoro, K., Mayaud, P., Changalucha, J., Nicoll, A., ka-Gina, G., Newell, J., Mugeye, K., Mabey, D., Hayes, R. (1995), Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomized controlled trial, Lancet, 346, 530–536.
28. Hacke, W., Kaste, M., Fieschi, C., von Kummer, R., Davalos, A., Meier, D., Larrue, V., Bluhmki, E., Davis, S., Donnan, G., Schneider, D., Diez-Tejedor, E., Trouillas, P. for the Second European-Australasian Acute Stroke Study Investigators (1998), Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II), Lancet, 352, 1245–1251.
29. Hackett, A.F., Court, S., Matthews, J.N.S., McCowen, C., Parkin, J.M. (1989), Do education groups help diabetics and their parents? Archives of Disease in Childhood, 64, 997–1003.
30. Haybittle, J.L. (1971), Repeated assessment of results in clinical trials of cancer treatment, British Journal of Radiology, 44, 793–797.
31. Hill, A.B. (1962), Statistical Methods in Clinical and Preventive Medicine, Livingstone, Edinburgh.
32. Hommel, E., Parving, H.H., Mathiesen, E., Edsberg, B., Damkjaer Nielsen, M., Giese, J. (1986), Effect of Captopril on kidney function in insulin-dependent diabetic patients with nephropathy, British Medical Journal, 293, 467–470.
33. Kinmonth, A.L., Woodcock, A., Griffin, S., Spiegal, N., Campbell, M.J. (1998), Randomised controlled trial of patient centred care of diabetes in general practice: impact on current well being and future disease, British Medical Journal, 317, 1202–1208.
34. Lan, K.K.G., DeMets, D.L. (1983), Discrete sequential boundaries for clinical trials, Biometrika, 70, 659–663.
35. Machin, D., Campbell, M.J., Fayers, P.M., Pinol, A.P.Y. (1997), Sample Size Tables for Clinical Studies, 2nd ed., Blackwell, Oxford.
36. Mantel, N., Haenszel, W. (1959), Statistical aspects of the analysis of data from retrospective studies of disease, Journal of the National Institute of Cancer, 22, 719–748.
37. McCullagh, P., Nelder, J.A. (1989), Generalized Linear Models, 2nd ed., Chapman & Hall/CRC Press, Boca Raton, FL.
38. McPherson, C.K., Armitage, P. (1971), Repeated significance tests on accumulating data when the null hypothesis is not true, Journal of the Royal Statistical Society: Series A, 134, 15–25.
39. MIST Study Group (1998), Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections, Lancet, 352, 1877–1881 (Erratum vol. 353, 504).
40. Newcombe, R.G. (1998), Interval estimation for the difference between independent proportions: comparison of eleven methods, Statistics in Medicine, 17, 873–890.
41. O’Brien, P.C. (1984), Procedures for comparing samples with multiple endpoints, Biometrics, 40, 1079–1087.
42. O’Brien, P.C., Fleming, T.R. (1979), A multiple testing procedure for clinical trials, Biometrics, 35, 549–556.
43. Peto, R., Pike, M.C., Armitage, P., Breslow, N.E., Cox, D.R., Howard, S.V., Mantel, N., McPherson, K., Peto, J., Smith, P.G. (1976), Design and analysis of randomized clinical trials requiring prolonged observation of each patient: I, Introduction and design, British Journal of Cancer, 34, 585–612.
44. Piantadosi, S. (2005), Clinical Trials: A Methodologic Perspective, 2nd ed., Wiley, Chichester.
45. Pocock, S.J. (1977), Group sequential methods in the design and analysis of clinical trials, Biometrika, 64, 191–199.
46. Pocock, S.J. (1993), Statistical and ethical issues in monitoring clinical trials, Statistics in Medicine, 12, 1459–1469.
47. Richards, S.H., Coast, J., Gunnell, D.J., Peters, T.J., Pounsford, J., Darlow, M.-A. (1998), Randomised controlled trial comparing effectiveness and acceptability of an early discharge, hospital at home scheme with acute hospital care, British Medical Journal, 316, 1796–1801 (Erratum vol. 317, 786).
48. Robins, J.M., Breslow, N., Greenland, S. (1986), Estimators of the Mantel-Haenszel variance consistent in both sparse and large-strata limiting models, Biometrics, 42, 311–323.
49. Robinson, L.D., Jewell, N.P. (1991), Some surprising results about covariate adjustment in logistic regression models, International Statistical Review, 58, 227–240.
50. Rosenberger, W.F., Lachin, J.M. (2002), Randomization in Clinical Trials: Theory and Practice, Wiley, Chichester.
51. Scandinavian Simvastatin Survival Study Group (1994), Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study Lancet, 344, 1383–1389.
52. Senn, S.J., Auclair, P. (1990), The graphical representation of clinical trials with particular reference to measurements over time, Statistics in Medicine, 9, 1287–1302 (Erratum: Statistics in Medicine, 10, 487).
53. Simes, R.J. (1986), An improved Bonferroni procedure for multiple tests of significance, Biometrika, 73, 751–754.
54. Smith, A.C., Dowsett, J.F., Russell, R.C.G., Hatfield, A.R.W., Cotton, P.B. (1994), Randomised trial of endoscopic stenting versus surgical bypass in malignant low bileduct obstruction, Lancet, 344, 1655–1660.
55. Spiegelhalter, D.J., Abrams, K.R., Myles, J.P. (2003), Bayesian Approaches to Clinical Trials and Health-Care Evaluation, Wiley, Chichester.
56. Tate, J.J.T., Dawson, J.W., Chung, S.C.S., Lau, W.Y., Li, A.K.C. (1993), Laparoscopic versus open appendectomy — prospective randomized trial, Lancet, 342, 633–637.
57. Thompson, S.G. (1993), Controversies in meta-analysis: the case of the trials of serum cholesterol reduction, Statistical Methods in Medical Research, 2, 173–192.
58. Ware, J.H. (1989), Investigating therapies of potentially great benefit: ECMO, Statistical Science, 4, 298–340.
59. Wei, L.J. (1977), A class of designs for sequential clinical trials, Journal of the American Statistical Association, 72, 382–386.
60. Wei, L.J. (1978), An application of an urn model to the design of sequential controlled clinical trials, Journal of the American Statistical Association, 73, 559–563.
61. Whitehead, J. (1992), The Design and Analysis of Sequential Clinical Trials, 2nd ed., Ellis Horwood, Chichester.
62. Winston, D.J., Wirin, D., Shaked, A., Busuttil, R.W. (1995), Randomised comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipients, Lancet, 346, 69–74.